Skip to content

Free cash flow at other companies

Procter & Gamble logo
Procter & GamblePG
$3.03B+6.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Bausch + Lomb logo
Bausch + LombBLCO
-$68M+49.6%
Cencora logo
CencoraCOR
-$2.42B+14.2%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$70.66M-51.6%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Prestige Consumer Healthcare’s reported figures.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's free cash flow?
Prestige Consumer Healthcare (PBH) reported free cash flow of $37.63M in Q1 2026.
How has Prestige Consumer Healthcare's free cash flow changed year-over-year?
Prestige Consumer Healthcare's free cash flow decreased by 35.5% year-over-year, from $58.37M to $37.63M.
What is the long-term trend for Prestige Consumer Healthcare's free cash flow?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's free cash flow has grown at a -0.4% compound annual growth rate (CAGR), from $250.28M to $246.45M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.